Daiki Ogawara Hiroshi Soda Keisuke Iwasaki Takayuki Suyama Hirokazu Taniguchi Yuichi Fukuda Hiroshi Mukae
10.1111/1759-7714.12543
Thorac Cancer
2018 Jan;9(1):175-180.
chemotherapy immunotherapy non-small cell lung cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29063735/
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Lung Neoplasms / drug therapy Salvage Therapy / methods
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Lung Neoplasms / drug therapy Salvage Therapy / methods Case Reports Aged Antibodies, Monoclonal / pharmacology Antineoplastic Agents / pharmacology Female Humans Lung Neoplasms / pathology Male Nivolumab Antibodies, Monoclonal Antineoplastic Agents Nivolumab
PMC5754301
29063735
Remarkable response of nivolumab-refractory lung cancer to salvage chemotherapy
2018